Transthyretin Amyloidosis trials recruiting in Missouri

Fewer than 3 recruiting trials found.

All Transthyretin Amyloidosis trials nationally

Cities in Missouri

Recruiting trials in Missouri

• Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
  NCT06563895 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Missouri: Kansas City, St Louis
• Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
  NCT07695701 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Missouri: St Louis